Australia markets closed

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
3.5300+0.0200 (+0.57%)
At close: 05:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 712.47M
Enterprise value 948.48M
Trailing P/E 3.99
Forward P/E 13.07
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.72
Price/book (mrq)3.07
Enterprise value/revenue 0.96
Enterprise value/EBITDA 2.62

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-21.21%
S&P500 52-week change 3-16.62%
52-week high 36.3900
52-week low 33.4400
50-day moving average 34.4738
200-day moving average 34.9432

Share statistics

Avg vol (3-month) 31.48M
Avg vol (10-day) 31.79M
Shares outstanding 5201.83M
Implied shares outstanding 6N/A
Float 8120.36M
% held by insiders 18.83%
% held by institutions 146.20%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.82
Forward annual dividend yield 423.23%
Trailing annual dividend rate 30.53
Trailing annual dividend yield 315.10%
5-year average dividend yield 4N/A
Payout ratio 413.57%
Dividend date 3N/A
Ex-dividend date 423 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 17.90%
Operating margin (ttm)27.52%

Management effectiveness

Return on assets (ttm)30.79%
Return on equity (ttm)113.46%

Income statement

Revenue (ttm)995.6M
Revenue per share (ttm)4.95
Quarterly revenue growth (yoy)39.20%
Gross profit (ttm)762.63M
EBITDA 286.36M
Net income avi to common (ttm)178.24M
Diluted EPS (ttm)0.8800
Quarterly earnings growth (yoy)1,355.50%

Balance sheet

Total cash (mrq)27.51M
Total cash per share (mrq)0.14
Total debt (mrq)262.38M
Total debt/equity (mrq)112.82
Current ratio (mrq)0.63
Book value per share (mrq)1.16

Cash flow statement

Operating cash flow (ttm)284.09M
Levered free cash flow (ttm)250.39M